Research Article
Role of P-Glycoprotein Inhibitors in the Bioavailability Enhancement of Solid Dispersion of Darunavir
Figure 5
Plasma concentration profile of DRV following oral administration of different formulations in (a) fasted state and (b) fed state. Data presented as mean ± SD, for each formulation.
(a) |
(b) |